[
  {
    "ts": null,
    "headline": "What Boston Scientific’s 34% Rally Means After Upbeat FDA Heart Device News",
    "summary": "Thinking about what to do with Boston Scientific stock? You are not alone. In the last year, BSX has shot up an impressive 34%, extending what has been a powerhouse run over the past several years. If you have been watching from the sidelines, or even pondering whether it is time to lock in some gains, the stock’s recent momentum naturally raises one question: have things run too far, too fast, or is there more room to grow? Just in the last 90 days, BSX shares have gained nearly 1.6%,...",
    "url": "https://finnhub.io/api/news?id=d935eac3d85b8beebd54b67e5ff2acafaa818bafedfd7fad9974efdd47f381b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756029942,
      "headline": "What Boston Scientific’s 34% Rally Means After Upbeat FDA Heart Device News",
      "id": 136502711,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Thinking about what to do with Boston Scientific stock? You are not alone. In the last year, BSX has shot up an impressive 34%, extending what has been a powerhouse run over the past several years. If you have been watching from the sidelines, or even pondering whether it is time to lock in some gains, the stock’s recent momentum naturally raises one question: have things run too far, too fast, or is there more room to grow? Just in the last 90 days, BSX shares have gained nearly 1.6%,...",
      "url": "https://finnhub.io/api/news?id=d935eac3d85b8beebd54b67e5ff2acafaa818bafedfd7fad9974efdd47f381b7"
    }
  }
]